Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC-Reference-Cited by-同舟云学术

Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC

Published:2005 Issue:8 Volume:19 Page:570-578
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomed. Chromatogr.

Author:

Arzuaga A.,Isla A.,Gascón A. R.,Maynar J.,Martín A.,Solinís M. A.,Toral D.,Pedraz J. L.

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Reference21 articles.

1. Analysis of piperacillin using high-performance liquid chromatography

2. Influence of Renal Function on the Pharmacokinetics of Piperacillin/Tazobactam in Intensive Care Unit Patients During Continuous Venovenous Hemofiltration

3. High-performance liquid chromatographic determination of tazobactam and piperacillin in human plasma and urine

4. Simple and rapid determination of piperacillin and ceftazidime in human plasma samples by HPLC

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on recent analytical methodologies developed for the micro-determination of piperacillin in different matrices;Microchemical Journal;2024-10

2. Preanalytical Stability of 13 Antibiotics in Biological Samples: A Crucial Factor for Therapeutic Drug Monitoring;Antibiotics;2024-07-20

3. Quantitation of 10 antibiotics in plasma: Sulfosalicylic acid combined with 2D-LC-MS/MS is a robust assay for beta-lactam therapeutic drug monitoring;Journal of Chromatography B;2023-04

4. Simple HPLC-UV Method for Piperacillin/Tazobactam Assay in Human Plasma;Antibiotics;2023-02-03

5. Simultaneous infusion of two incompatible antibiotics: Impact of the choice of infusion device and concomitant simulated fluid volume support on the particulate load and the drug mass flow rates;International Journal of Pharmaceutics;2022-11